Hosted on MSN

Biomerica announces launch of inFoods IBS Trigger Food Navigator

Biomerica (BMRA) announced the launch of its inFoods IBS Trigger Food Navigator, an AI-backed digital companion tool designed to better enable patient dietary compliance and improve treatment success ...
Yahoo Finance

Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment

IRVINE, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it is nearing completion of patient enrollment in the ...
Yahoo Finance

Biomerica provides update on inFoods® IBS expansion

- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in physicians prescribing inFoods more ...
Nasdaq

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, is pleased to announce that inFoods® IBS, ...
manilatimes

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® ...
The Globe and Mail

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods ® IBS testing IBS affects an estimated 40 million adults in the U.S.
manilatimes

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic solutions, is proud to announce that its inFoods® IBS ...
Finanznachrichten

Biomerica, Inc.: Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

The inFoods ® IBS test was designed specifically for IBS patients. It identifies individual foods that trigger an elevated (above normal) Immunoglobulin G (IgG) antibody responses-which is a marker of ...
Hosted on MSN

Biomerica announces inFoods IBS product featured in Biotherapeutics Quarterly

Biomerica (BMRA) announced that its inFoods IBS diagnostic-guided therapy product is being featured in the Fall 2025 issue of Biotherapeutics Quarterly. The article, titled “Precision Medicine for IBS ...
The Globe and Mail

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

inFoods ® IBS provides personalized identification of food triggers to substantially improve IBS-related symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif., July 02, ...
Taiwan News

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS) Research Finds Patients Following a Personalized Diet Therapy Created with inFoods ® IBS, ...